With the launch of the new Flamingo Music and Flamingo Mobile stereo earphones, which are targeted against iPods, MP3 players, iPhones and other multimedia mobile phones, and intense sales activities over the last few months, CellPoint has experienced a strong growth in incoming orders.
The
orders have come from both new and existing channels in North America and Europe,
but the largest increase is being seen in the Asia-Pacific region from new customers.
CellPoint
anticipates this region will be a key contributor to growth in the future.
The
company’s order backlog is now more then 150 000 units, with a value of over
$7 million USD.
The
fact that the new Flamingo products, in the next few months, will be introduced
by professional local partners within these large markets creates a very
positive indication for CellPoint’s growth potential in the coming years.
For more information, contact:
Michael Mathiesen
Chairman
CellPoint Connect AB
+45 4045 3332
michael.mathiesen@cellpoint.com
CellPoint Connect AB (publ)
develops, manufactures and markets the Flamingo Bluetooth Headset, a wireless
headset using patent-pending EarClick²™ technology for a comfortable fit as
well as the nXZEN and nX6000 headsets with extreme ”noise cancellation”
technology. All products are compatible with Bluetooth devices such as mobile
phones and computers. Recently, CellPoint has launched two wired headsets,
Flamingo Music and Flamingo Mobile, which are compatible with iPod’s, MP3
players and iPhone’s and other leading multimedia mobile phones. CellPoint has
offices in Sweden, Denmark, Norway, China, Canada and the USA serving markets
throughout Europe, North America, Latin America and Asia. CellPoint is listed
on Stockholm’s AktieTorget (www.aktietorget.se) with the following ticker
symbol: CPNT. More information can be found at www.cellpoint.com
Disclaimer
This document may contain
forward-looking statements relating to CellPoint’s operations or to the
environment in which it operates, and CellPoint’s strategy, litigation and
investments, which are based on CellPoint’s operations, estimates, forecasts
and projections. These statements are not guarantees of future performance and
involve risks and uncertainties that are difficult to predict, and/or are
beyond CellPoint’s control. A number of important factors could cause actual
outcomes and results to differ materially from those expressed in these
forward-looking statements. These factors include those set forth in other
public filings. Consequently, readers should not place any undue reliance on
such forward-looking statements. In addition, these forward-looking statements
relate to the date on which they are made. CellPoint disclaims any intention or
obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
